Quantcast
Last updated on April 21, 2014 at 12:45 EDT

Latest Transdermal patch Stories

Electronic Patches That Stick To Your Skin For Health Monitoring
2014-04-04 14:14:50

[ Watch The Video: Stick-On Electronic Patches For Health Monitoring ] University of Illinois at Urbana-Champaign Wearing a fitness tracker on your wrist or clipped to your belt is so 2013. Engineers at the University of Illinois at Urbana-Champaign and Northwestern University have demonstrated thin, soft stick-on patches that stretch and move with the skin and incorporate commercial, off-the-shelf chip-based electronics for sophisticated wireless health monitoring. The patches...

2014-03-28 16:22:55

HIGH WYCOMBE, England, March 28, 2014 /PRNewswire/ -- FG Xpress launches a new revolutionary natural pain relief solution in the market. The PowerStrips from FG Xpress is a pain relief product designed to take away all kinds of muscle pains naturally and safely. The product is formulated with key ingredients that do not just target to lessen users' pain issues but also help rejuvenate their body. Generally, there are more than 1.5 billion people that suffer from pain....

2014-03-23 23:00:49

Top 10 Drug Delivery Technologies Market research report intensively evaluates drug delivery technologies with respect to revenues, growth, therapeutic areas, patents registered and industry focus to arrive at top 10 drug delivery technologies - http://www.marketsandmarkets.com/Market-Reports/top-10-drug-delivery-technologies-112.html. (PRWEB) March 23, 2014 The ‘Global Top 10 Drug Delivery Technologies Market (2010 – 2015)’ analyzes the drug delivery technologies market by the top...

2014-03-04 23:22:24

The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal - http://www.marketsandmarkets.com/Market-Reports/drug-delivery-technologies-market-1085.html. (PRWEB) March 04, 2014 The "Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion...

2014-02-14 12:24:25

DUBLIN, February 14, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/477x2k/drug) have announced the addition of the "Drug Self-administration Markets to 2020" [http://www.researchandmarkets.com/research/477x2k/drug ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Therapeutic Indications, Product Strategies, Markets and Forecasts While alternative methods for delivering...

2014-02-11 12:26:50

DUBLIN, Feb. 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/n6j7k3/transdermal_drug ) has announced the addition of the "Transdermal Drug Patches to 2020" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Products, Indications, Markets and Forecasts Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the...

2014-01-23 23:22:31

GIA announces the release of a comprehensive global report on Hormone Replacement Therapy (HRT) markets. Global market for Hormone Replacement Therapy (HRT) is projected to exceed US$3.3 billion by 2020, driven by rising number of women in the menopausal age, and increase in patient awareness levels. San Jose, California (PRWEB) January 23, 2014 Follow us on LinkedIn – Hormone Replacement Therapy refers to use of hormones - estrogens and progestin for alleviating symptoms associated...

2014-01-02 23:22:46

Transparency Market Research Report added "Drug Device Combination Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its database. Browse full report with TOC: http://www.transparencymarketresearch.com/drug-device-combination.html. Albany, New York, USA (PRWEB) January 02, 2014 According to a new market report published by Transparency Market Research "Drug Device Combination Products Market (Drug Eluting Stents, Infusion...

2013-12-24 08:24:01

DUBLIN, Dec. 24, 2013 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the Company's subsidiary has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal Delivery System) for use by women to prevent pregnancy. The Company stated that it intends to work closely with the FDA to address the items raised in the complete response...